![Steven Kyriakos](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Steven Kyriakos
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Navrogen, Inc.
![]() Navrogen, Inc. Pharmaceuticals: MajorHealth Technology Navrogen, Inc. is a biotechnology company, which engages in the discovery and development of tumor produced HIO-factors that are associated with cancer prognosis and therapeutic response of immune-mediated anti-cancer therapies. The company was founded by Luigi Grasso and Nicholas C. Nicolaides in 2017 and is headquartered in Philadelphia, PA.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Steven Kyriakos tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Morphotek, Inc.
![]() Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Miscellaneous Commercial Services | Chief Executive Officer Founder | |
Dianthus Therapeutics, Inc. (Massachusetts)
![]() Dianthus Therapeutics, Inc. (Massachusetts) BiotechnologyHealth Technology Dianthus Therapeutics OpCo, Inc. provides heath care services. The company was founded by Jonathan Violin and is headquartered in Waltham, MA. | Biotechnology | Chairman | |
Temple University Japan | College/University | Chairman | |
ViTToria Biotherapeutics, Inc.
![]() ViTToria Biotherapeutics, Inc. BiotechnologyHealth Technology viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
Helsinn SA | Director/Board Member | ||
DIANTHUS THERAPEUTICS, INC. | Biotechnology | Chairman | |
Praeventix, Inc.
![]() Praeventix, Inc. BiotechnologyHealth Technology Praeventix, Inc. is a biotechnology company founded by Dr. Douglas Pippin based on discoveries researched by Dr. Pippin and at Temple University. The company is based in Exton, PA, and was founded by Douglas Pippin. The company is initially focused on the development of pre-clinical candidate pra-523, a potential first-in-class neuromodulatory therapy for pruritus and other potential indications, including IBD. Praeventix is pursuing novel serotonergic therapeutics for inflammatory bowel disease (IBD) and cocaine use disorder (CUD). Douglas Pippin has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Zenas Pharma, Inc.
![]() Zenas Pharma, Inc. BiotechnologyHealth Technology Zenas Pharma, Inc. is an American pharmaceutical company that is focused on developing a portfolio of first- and autoimmune therapeutics to address areas of high unmet medical need. The company is located in the US. The company's lead product candidate, obexelimab (zb012), is a novel bifunctional antibody with first-in-class potential that inhibits B-cell lineages that express CD19. | Biotechnology | Chief Executive Officer | |
Thomas Jefferson University | College/University | Doctorate Degree | |
Interius BioTherapeutics, Inc.
![]() Interius BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Interius BioTherapeutics, Inc. is a biopharmaceutical company that targets cancer. The company was founded by Saar Gill and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
St. Joseph's University | College/University | Undergraduate Degree | |
ZYLA LIFE SCIENCES | Pharmaceuticals: Major | Director/Board Member | |
New York Academy of Sciences
![]() New York Academy of Sciences Miscellaneous Commercial ServicesCommercial Services New York Academy of Sciences is an independent, not-for-profit organization, which engages in the advancement of scientific research, education, and policy. The company was founded in 1817 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
American Association for Cancer Research
![]() American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
TamuroBio, Inc.
![]() TamuroBio, Inc. Miscellaneous Commercial ServicesCommercial Services Tamurobio, Inc. provides biotechnology services. The company was founded in 2019 and is headquartered in Wayne, PA. | Miscellaneous Commercial Services | Director/Board Member | |
Tellus Bioventures LLC
![]() Tellus Bioventures LLC Investment ManagersFinance Tellus BioVentures LLC (Tellus BioVentures) is a venture capital firm founded in 2019 by Leon O. Moulder. The firm is headquartered in Miromar Lakes, Florida. | Investment Managers | Chief Executive Officer | |
Aegle Therapeutics Corp.
![]() Aegle Therapeutics Corp. BiotechnologyHealth Technology Aegle Therapeutics Corp. is a biotechnology company, which isolates extracellular vesicles including exosomes (“EVs”) secreted by allogeneic bone marrow derived mesenchymal stem cells to treat dystrophic epidermolysis bullosa (“DEB”), a rare pediatric connective tissue disorder. Its EV therapy has the potential to demonstrate a safer, lower cost means of harnessing the regenerative healing power of stem cells without using the cells. The company was founded by Evangelos V. Badiavas, and Robert F. Williamson III in 2013 and is headquartered in Miami, FL. | Biotechnology | Director/Board Member | |
TREVENA, INC. | Pharmaceuticals: Major | Chairman | |
MGI PHARMA Biologics, Inc.
![]() MGI PHARMA Biologics, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA Biologics, Inc. develops and markets pharmaceutical and medical therapies. The company's products amolimogene and ZYC300 represent a breakthrough in the activition of cytotoxic cells. The company was founded in 1979 and is located in Lexington, MA | Pharmaceuticals: Major | Chief Executive Officer | |
Hoechst Marion Roussel, Inc. | Corporate Officer/Principal | ||
Eisai Corp. of North America
![]() Eisai Corp. of North America Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., Eisai Corp. of North America is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Eligix, Inc.
![]() Eligix, Inc. Medical/Nursing ServicesHealth Services Eligix, Inc. develops and distributes medicines. It also offers cellular transplantation and immune therapies to enhance human immune response to cancers and infectious diseases. The company is located in Medford, MA | Medical/Nursing Services | Corporate Officer/Principal | |
CUBIST PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member | |
TESARO INC | Pharmaceuticals: Major | Founder | |
Temple University (Pennsylvania) | College/University | Director/Board Member | |
Temple University Hospital, Inc.
![]() Temple University Hospital, Inc. Hospital/Nursing ManagementHealth Services Temple University Hospital, Inc. owns and operates a healthcare centre. The company provides pulmonology, cardiology, gastroenterology, hematology, nephrology, oncology, neurology, ophthalmology, otorhinolaryngology, and bone marrow transplantation services. Additionally, it offers heart, lung, kidney, and trauma surgery; maxillofacial surgery; psychiatry; radiation oncology; and diagnostic imaging services. The company also provides treatment of infectious diseases and diabetes. The company was founded in 1992 and is headquartered in Philadelphia, PA. | Hospital/Nursing Management | Corporate Officer/Principal | |
MIRATI THERAPEUTICS | Biotechnology | Director/Board Member | |
The Fox Chase Cancer Center
![]() The Fox Chase Cancer Center Hospital/Nursing ManagementHealth Services The Fox Chase Cancer Center owns and operates hospitals. It is an independent, non-profit institution that is engaged in cancer treatment, research and prevention services. The firm's staff provides consultations and treatment recommendations for different types of adult cancer. The company was founded in 1904 and is headquartered in Philadelphia, PA. | Hospital/Nursing Management | Director/Board Member | |
The University of Chicago Booth School of Business | College/University | Corporate Officer/Principal | |
Helsinn Healthcare SA
![]() Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
ZAI LAB LIMITED | Biotechnology | Director/Board Member | |
University of Catania | College/University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 34 |
Svizzera | 3 |
Giappone | 2 |
Canada | 2 |
Cina | 2 |
Settori
Health Technology | 21 |
Consumer Services | 7 |
Commercial Services | 6 |
Health Services | 4 |
Finance | 2 |
Posizioni
Director/Board Member | 25 |
Corporate Officer/Principal | 9 |
Chief Executive Officer | 8 |
Founder | 7 |
Chairman | 6 |
Contatti più connessi
Insiders | |
---|---|
Lonnie Moulder | 31 |
Nicholas C. Nicolaides | 10 |
Luigi Grasso | 3 |
- Borsa valori
- Insiders
- Steven Kyriakos
- Connessioni Società